SBFM
Sunshine Biopharma·NASDAQ
--
--(--)
--
--(--)
1.00 / 10
Underperform
With an aggregate technical rating of 1.0/10, the stock exhibits challenging technical structure. Favorable signals from no significant factors are partially offset by weaknesses in MACD Death Cross, Long Upper Shadow, and Long Lower Shadow. The technical profile supports a cautious stance.
Analysis Checks(0/3)
Long Upper Shadow
Score1/10
Win Rate28.00%
Hist. Signals50
Avg Return-3.28%
Score1/10
Win Rate28.00%
Hist. Signals50
Avg Return-3.28%
MACD Death Cross
Score1/10
Win Rate28.57%
Hist. Signals14
Avg Return-5.32%
Score1/10
Win Rate28.57%
Hist. Signals14
Avg Return-5.32%
Long Lower Shadow
Score1/10
Win Rate32.61%
Hist. Signals46
Avg Return-1.60%
Score1/10
Win Rate32.61%
Hist. Signals46
Avg Return-1.60%
Long Upper Shadow
Score1/10
Win Rate28.00%
Hist. Signals50
Avg Return-3.28%
Score1/10
Win Rate28.00%
Hist. Signals50
Avg Return-3.28%
Long Lower Shadow
Score1/10
Win Rate32.61%
Hist. Signals46
Avg Return-1.60%
Score1/10
Win Rate32.61%
Hist. Signals46
Avg Return-1.60%
MACD Death Cross
Score1/10
Win Rate28.57%
Hist. Signals14
Avg Return-5.32%
Score1/10
Win Rate28.57%
Hist. Signals14
Avg Return-5.32%
What is the current technical signals for SBFM?
- SBFM presents a Underperform setup with a Technical Score of 1.00/10. Key technical indicators highlight an RSI of 41.56 and a MACD of -0.00, with the trend anchored by the 50-Day SMA at 1.32. Traders should monitor key support at 1.13 and resistance at 1.19.
